GM09548
LCL from B-Lymphocyte
Description:
PELIZAEUS-MERZBACHER DISEASE; PMD
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of the Nervous System |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Ethnicity
|
ITALIAN
|
Family Member
|
4
|
Relation to Proband
|
mother
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
MYELIN PROTEINS AND METABOLISM |
Gencic et al (Am J Hum Genet 45:435-442,1989) reported that DNA from this cell culture showed a single base transition (C to T) in exon 5 of the myelin proteolipid protein gene which causes a serine substitution for proline at the carboxy end of the protein. |
|
Gene |
PLP1 |
Chromosomal Location |
Xq22 |
Allelic Variant 1 |
300401.0001; PELIZAEUS-MERZBACHER DISEASE |
Identified Mutation |
PRO215SER; Gencic et al. [Am. J. Hum. Genet. 45: 435 (1989)] described a missense mutation in exon 5 of the PLP gene, with a C-to-T transition creating a serine substitution for proline at the carboxy end of the protein, in a patient with the classic form (type I) of PMD. |
Remarks |
Two affected sons; clinically unaffected; 4 unaffected brothers; donor subject has a C>T transition at nucleotide 767 (767C>T) in exon 5 of the PLP1 gene resulting in a missense mutation, a substitution of serine for proline at codon 215 [Pro215Ser (P215S)] |
Gencic S, Abuelo D, Ambler M, Hudson LD, Pelizaeus-Merzbacher disease: an X-linked neurologic disorder of myelin metabolism with a novel mutation in the gene encoding proteolipid protein. Am J Hum Genet45:435-42 1989 |
PubMed ID: 2773936 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|